Rajesh Valanparambil, Jennifer Carlisle, Susanne Linderman, Akil Akthar, Ralph Linwood Millett, Lilin Lai, Andres Chang, Ashley McCook, Jeffrey Switchenko, Tahseen Nasti, Manpreet Saini, Andreas Wieland Andreas Wieland, Kelly Manning, Madison Ellis, Kathryn Moore, Stephanie Foster, Katharine Floyd, Meredith Davis-Gardner, Venkata Viswanadh Edara, Mit Patel, Conor Steur, Ajay Nooka, Felicia Green, Margaret Johns, Fiona O Brein, Uma Shanmugasundaram, Veronika Zarnitsyna, Hasan Ahmed, Lindsay Nyhoff, Grace Mantus, Michael Garett, Srilatha Edupuganti, Madhusmita Behra, Rustom Antia, Jens Wrammert, Mehul Suthar, Madhav Dhodapkar, Suresh Ramalingam, Rafi Ahmed
PURPOSE: We investigated SARS-CoV-2 mRNA vaccine-induced binding and live-virus neutralizing antibody response in NSCLC patients to the SARS-CoV-2 wild type strain and the emerging Delta and Omicron variants. METHODS: 82 NSCLC patients and 53 healthy adult volunteers who received SARS-CoV-2 mRNA vaccines were included in the study. Blood was collected longitudinally, and SARS-CoV-2-specific binding and live-virus neutralization response to 614D (WT), B.1.617.2 (Delta), B...
January 23, 2022: medRxiv